(R)-Carisbamate
95%
- Product Code: 37260
CAS:
194085-74-0
| Molecular Weight: | 215.6336 g./mol | Molecular Formula: | C₉H₁₀ClNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
(R)-Carisbamate is primarily investigated for its potential therapeutic applications in the treatment of central nervous system disorders. It has shown promise as an anticonvulsant, particularly in managing epilepsy, due to its ability to modulate neuronal excitability. Research suggests it may also be effective in alleviating neuropathic pain by targeting specific pathways involved in pain signaling. Additionally, (R)-Carisbamate is being studied for its neuroprotective properties, which could be beneficial in conditions like stroke or neurodegenerative diseases. Its unique mechanism of action, distinct from other antiepileptic drugs, makes it a candidate for patients who do not respond to conventional treatments. Ongoing clinical trials aim to further explore its efficacy and safety in these applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $71.42 |
+
-
|
| 0.250 | 10-20 days | $141.49 |
+
-
|
| 1.000 | 10-20 days | $505.37 |
+
-
|
(R)-Carisbamate
(R)-Carisbamate is primarily investigated for its potential therapeutic applications in the treatment of central nervous system disorders. It has shown promise as an anticonvulsant, particularly in managing epilepsy, due to its ability to modulate neuronal excitability. Research suggests it may also be effective in alleviating neuropathic pain by targeting specific pathways involved in pain signaling. Additionally, (R)-Carisbamate is being studied for its neuroprotective properties, which could be beneficial in conditions like stroke or neurodegenerative diseases. Its unique mechanism of action, distinct from other antiepileptic drugs, makes it a candidate for patients who do not respond to conventional treatments. Ongoing clinical trials aim to further explore its efficacy and safety in these applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :